Investigations of Mycoplasma pneumoniae infections in the United States: Trends in molecular typing and macrolide resistance from 2006 to 2013

Journal of Clinical Microbiology

Volumn 53, Issue 1, 2015, Pages 124-130

  Diaz, Maureen H ^a   Benitez, Alvaro J ^a   Winchell, Jonas M ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROLIDE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC TEST; DISEASE SEVERITY; DISEASE SURVEILLANCE; DOCUMENTATION; EPIDEMIC; GENETIC ANALYSIS; HUMAN; INFECTION CONTROL; MOLECULAR TYPING; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; UNITED STATES; ADOLESCENT; ADULT; CHILD; CLASSIFICATION; DRUG EFFECTS; GENETICS; HEALTH SURVEY; HISTORY; INFANT; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; NEWBORN; PNEUMONIA, MYCOPLASMA; PRESCHOOL CHILD; YOUNG ADULT;

MYCOPLASMA PNEUMONIAE;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; HISTORY, 21ST CENTURY; HUMANS; INFANT; INFANT, NEWBORN; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR TYPING; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; POPULATION SURVEILLANCE; UNITED STATES; YOUNG ADULT;

EID: 84919498931     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02597-14     Document Type: Article

References (34)

1. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM, Musher DM, Niederman MS, Torres A, Whitney CG. 2007. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44:S27-S72. http://dx.doi.org/10.1086/511159.
2. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL, Mace SE, McCracken GH, Moore MR, St Peter SD, Stockwell JA, Swanson JT. 2011. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 53:e25-e76. http://dx.doi.org/10.1093/cid/cir531.
3. Atkinson TP, Balish MF, Waites KB. 2008. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev 32:956-973. http://dx.doi.org/10.1111/j.1574-6976.2008.00129.x.
4. Waites KB, Talkington DF. 2004. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 17:697-728. http://dx.doi.org/10.1128/CMR.17.4.697-728.2004.
5. Winchell JM. 2013. Mycoplasma pneumoniae-a national public health perspective. Curr Pediatr Rev 9:324-333. http://dx.doi.org/10.2174/15733963113099990009.
6. Liu Y, Ye X, Zhang H, Xu X, Li W, Zhu D, Wang M. 2009. Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China. Antimicrob Agents Chemother 53:2160-2162. http://dx.doi.org/10.1128/AAC.01684-08.
7. Xin D, Mi Z, Han X, Qin L, Li J, Wei T, Chen X, Ma S, Hou A, Li G, Shi D. 2009. Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China. Antimicrob Agents Chemother 53:2158-2159. http://dx.doi.org/10.1128/AAC.01563-08.
8. Newell L, Burke P, Woods J, Posey R, Smith B, Ibrahim SM, Bixler D, Haddy L, Shwe T, Radcliffe R, Benitez A, Thurman KA, Diaz MH, Wolff BJ, Warner A, Winchell JM, Conklin LM, Barbour K, Fleming-Dutra KE, Steinhardt LC. 2012. Mycoplasma pneumoniae respiratory illness-two rural counties, West Virginia, 2011. Morb Mortal Wkly Rep 61:834-838.
9. Wolff BJ, Thacker WL, Schwartz SB, Winchell JM. 2008. Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high resolution melt analysis. Antimicrob Agents Chemother 52:3542-3549. http://dx.doi.org/10.1128/AAC.00582-08.
10. Yamada M, Buller R, Bledsoe S, Storch GA. 2012. Rising rates of macrolideresistant Mycoplasma pneumoniae in the central United States. Pediatr Infect Dis J 31:409-411. http://dx.doi.org/10.1097/INF.0b013e318247f3e0.
11. Cao B, Zhao CJ, Yin YD, Zhao F, Song SF, Bai L, Zhang JZ, Liu YM, Zhang YY, Wang H, Wang C. 2010. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis 51:189-194. http://dx.doi.org/10.1086/653535.
12. Cardinale F, Chironna M, Chinellato I, Principi N, Esposito S. 2013. Clinical relevance of Mycoplasma pneumoniae macrolide resistance in children. J Clin Microbiol 51:723-724. http://dx.doi.org/10.1128/JCM.02840-12.
13. Matsubara K, Morozumi M, Okada T, Matsushima T, Komiyama O, Shoji M, Ebihara T, Ubukata K, Sato Y, Akita H, Sunakawa K, Iwata S. 2009. A comparative clinical study of macrolide-sensitive and macrolideresistant Mycoplasma pneumoniae infections in pediatric patients. J Infect Chemother 15:380-383. http://dx.doi.org/10.1007/s10156-009-0715-7.
14. Matsuoka M, Narita M, Okazaki N, Ohya H, Yamazaki T, Ouchi K, Suzuki I, Andoh T, Kenri T, Sasaki Y, Horino A, Shintani M, Arakawa Y, Sasaki T. 2004. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother 48:4624-4630. http://dx.doi.org/10.1128/AAC.48.12.4624-4630.2004.
15. Morozumi M, Iwata S, Hasegawa K, Chiba N, Takayanagi R, Matsubara K, Nakayama E, Sunakawa K, Ubukata K, the Acute Respiratory Diseases Study Group. 2008. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. Antimicrob. Agents Chemother 52:348-350. http://dx.doi.org/10.1128/AAC.00779-07.
16. Suzuki S, Yamazaki T, Narita M, Okazaki N, Suzuki I, Adoh T, Matsuoka M, Kenri T, Arakawa Y, Sasaki T. 2006. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicrob Agents Chemother 50:709-712. http://dx.doi.org/10.1128/AAC.50.2.709-712.2006.
17. Winchell JM, Thurman KA, Mitchell SL, Thacker WL, Fields BS. 2008. Evaluation of three real-time PCR assays for the detection of Mycoplasma pneumoniae in an outbreak investigation. J Clin Microbiol 46:3116-3118. http://dx.doi.org/10.1128/JCM.00440-08.
18. Thurman KA, Warner AK, Cowart KC, Benitez AJ, Winchell JM. 2011. Detection of Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella spp. in clinical specimens using a single-tube multiplex real-time PCR assay. Diagn Microbiol Infect Dis 70:1-9. http://dx.doi.org/10.1016/j.diagmicrobio.2010.11.014.
19. Thurman KA, Walter ND, Schwartz SB, Mitchell SL, Dillon MT, Deutscher M, Fulton JP, Tongren JE, Hicks LA, Winchell JM. 2009. Comparison of laboratory diagnostic procedures for detection of Mycoplasma pneumoniae in community outbreaks. Clin Infect Dis 48:1244-1249. http://dx.doi.org/10.1086/597775.
20. Benitez AJ, Diaz MH, Wolff BJ, Pimentel G, Njenga MK, Estevez A, Winchell JM. 2012. Multilocus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical isolates from 1962 to the present: a retrospective study. J Clin Microbiol 50:3620-3626. http://dx.doi.org/10.1128/JCM.01755-12.
21. Sun H, Xue G, Yan C, Li S, Cao L, Yuan Y, Zhao H, Feng Y, Wang L, Fan Z. 2013. Multiple-locus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical specimens and proposal for amendment of MLVA nomenclature. PLoS One 8:e64607. http://dx.doi.org/10.1371/journal.pone.0064607.
22. Waller JL, Diaz MH, Petrone BL, Benitez AJ, Wolff BJ, Edison L, Tobin-D'Angelo M, Moore A, Martyn A, Dishman H, Drenzek CL, Turner K, Hicks LA, Winchell JM. 2014. Detection and characterization of Mycoplasma pneumoniae during an outbreak of respiratory illness at a university. J Clin Microbiol 52:849-853. http://dx.doi.org/10.1128/JCM.02810-13.
23. Schwartz SB, Thurman KA, Mitchell SL, Wolff BJ, Winchell JM. 2009. Genotyping of Mycoplasma pneumoniae isolates using real-time PCR and high-resolution melt analysis. Clin Microbiol Infect 15:756-762. http://dx.doi.org/10.1111/j.1469-0691.2009.02814.x.
24. Jain S, Ampofo K, Arnold SR, Williams DJ, Anderson E, Bramley AM, Hymas W, Kaufman RA, Self WH, Erdman D, Winchell JM, Carvalho G, Lindstrom S, Chappell JD, Patel A, Hillyard D, Grijalva CG, Schneider E, Hicks L, Wunderink RG, Edwards KM, McCullers JA, Pavia AT, Finelli L. 2012. Etiology of community-acquired pneumonia among hospitalized children in the United States: preliminary data from the CDC Etiology of Pneumonia in the Community (EPIC) Study, abstr 168. 49th Annu Meet Infectious Diseases Society of America, Boston, MA.
25. Foy HM, Grayston JT, Kenny G, Alexander E, McMahan R. 1966. Epidemiology of Mycoplasma pneumoniae infection in families. JAMA 197:859-866. http://dx.doi.org/10.1001/jama.1966.03110110083019.
26. Walter ND, Grant GB, Bandy U, Alexander NE, Winchell JM, Jordan HT, Sejvar JJ, Hicks LA, Gifford DR, Alexander NT, Thurman KA, Schwartz SB, Dennehy PH, Khetsuriani N, Fields BS, Dillion MT, Erdman DD, Whitney CG, Moore MR. 2008. Community outbreak of Mycoplasma pneumoniae infection: school-based cluster of neurologic disease associated with household transmission of respiratory illness. J Infect Dis 198:1365-1374. http://dx.doi.org/10.1086/592281.
27. Dumke R, von Baum H, Luck PC, Jacobs E. 2010. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect 16:613-616. http://dx.doi.org/10.1111/j.1469-0691.2009.02968.x.
28. Pereyre S, Charron A, Renaudin H, Bebear CM, Bébéar CM. 2007. First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years. J Clin Microbiol 45:3534-3539. http://dx.doi.org/10.1128/JCM.01345-07.
29. Uldum SA, Bangsborg JM, Gahrn-Hansen B, Ljung R, Molvadgaard M, Fons Petersen R, Wiid Svarrer C. 2012. Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011. Euro Surveill 17(5): pii=20073. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20073.
30. Ferguson GD, Gadsby NJ, Henderson SS, Hardie A, Kalima P, Morris AC, Hill AT, Cunningham S, Templeton KE. 2013. Clinical outcomes and macrolide resistance in Mycoplasma pneumoniae infection in Scotland, UK. J Med Microbiol 62:1876-1882. http://dx.doi.org/10.1099/jmm.0.066191-0.
31. Pereyre S, Charron A, Hidalgo-Grass C, Touati A, Moses AE, Nir-Paz R, Bebear C. 2012. The spread of Mycoplasma pneumoniae is polyclonal in both an endemic setting in France and in an epidemic setting in Israel. PLoS One 7:e38585. http://dx.doi.org/10.1371/journal.pone.0038585.
32. Dégrange S, Cazanave C, Charron A, Renaudin H, Bebear C, Bebear CM. 2009. Development of multiple-locus variable-number tandemrepeat analysis for the molecular typing of Mycoplasma pneumoniae. J Clin Microbiol 47:914-923. http://dx.doi.org/10.1128/JCM.01935-08.
33. Liu Y, Ye X, Zhang H, Xu X, Wang M. 2012. Multiclonal origin of macrolide-resistant Mycoplasma pneumoniae isolates as determined by multilocus variable-number tandem-repeat analysis. J Clin Microbiol 50: 2793-2795. http://dx.doi.org/10.1128/JCM.00678-12.
34. Lind K, Benzon MW, Jensen S, Clyde WA, Jr. 1997. A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946 to 1995. Eur J Epidemiol 13:581-586. http://dx.doi.org/10.1023/A:1007353121693.